Jci_page_head_homepage_01 Jci_page_head_homepage_02
Robin L. Davisson, Michael I. Oliverio, Thomas M. Coffman, Curt D. Sigmund
Published in Volume 106, Issue 1
J Clin Invest. 2000; 106(1):103–106 doi:10.1172/JCI10022
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Effect of the specific AT1 receptor antagonist losartan on central angiotensin-II–induced drinking. A summary of the water drinking effects elicited by ICV angiotensin II (200 ng) before and after ICV administration of losartan (10 μg) in wild-type mice (+/+) and in mice with gene-targeted deletions of AT1A (AT-1A–/–) or AT1B (AT-1B–/–) receptors. AP < 0.001 versus before losartan.